George Clinical Welcomes Cardio Union and the George Institute for Global Health's Establishment of the HEART HEALTH RESEARCH CENTER

Beijing, China, October 17, 2016 (Newswire.com) - ​George Clinical welcomes the establishment of the Heart Health Research Center, a collaborative initiative developed by Cardio Union, an emerging multi-disciplinary healthcare organisation and George Clinical’s parent organisation, The George Institute for Global Health.  The Heart Health Research Center (HHRC) will help to address the growing burden of cardiovascular disease in China and around the world. The new business entity will deliver high quality research to Chinese organisations that cater for patients at a high risk of cardiovascular disease.

China has one of the highest cardiovascular disease death rates in the world – it is estimated that one in five adults has some form of cardiovascular disease in China.

"This partnership will provide China with important new scientific information about the causes, prevention and treatment of cardiovascular disease, which is the leading cause of premature death in the Chinese population. In particular our focus will be on the management of irregular heartbeat, heart attacks, heart failure and stroke which affect tens of millions of Chinese people."

Professor Stephen MacMahon, Principal Director of The George Institute

“This partnership will provide China with important new scientific information about the causes, prevention and treatment of cardiovascular disease, which is the leading cause of premature death in the Chinese population.  In particular our focus will be on the management of irregular heartbeat, heart attacks, heart failure and stroke which affect tens of millions of Chinese people,” Professor Stephen MacMahon, Principal Director of The George Institute said. “[The Heart Health Research Center] will pair excellence in health care with excellence in medical research.”

The Heart Health Research Center’s key priorities are to:

• Provide high quality research services in the field of cardiovascular disease;
• Assist doctors, researchers and industry to obtain grants, design protocols, undertake research to the highest standards, and publish results in high-impact journals; 
• Integrate the best evidence into service delivery models for patients at a high risk of Cardiovascular disease;
• Promote better prevention and management of cardiovascular disease in China through multi-center randomised controlled trials, disease registries, and community surveillance studies;
• Provide training and capacity building activities in research methods, analysis and technical report writing.

George Clinical works closely with the George Institute in China, providing a full range of trial delivery services to support these important clinical research initiatives.

“George Clinical, China welcomes the opportunity to contribute to this exciting venture by providing our operational expertise to studies carried out under the auspices of the HHRC,” Philip Gregory, Managing Director of George Clinical, China said. “Our engagement with the HHRC will continue to grow George Clinical’s already robust cardiovascular research network and allow the venture to access project and data management services of the highest quality. We look forward to the HHRC transforming the way people at risk of cardiovascular disease are treated both in China and around the world.”  

These sentiments were echoed by Dr Marisa Petersen, Executive Director of George Clinical.   

“George Clinical welcomes the establishment of the HHRC; a fantastic initiative that brings together clinical and scientific leadership and research strength in an area of critical need. We will be proud to support this initiative through our operational trial delivery services.”

 About George Clinical

George Clinical is a leading independent clinical research organisation (CRO) in Asia with over 200 staff operating in 11 countries. George Clinical provides the full range of clinical trial services to pharmaceutical, medical device and biotech customers, for all trial phases, registration and post-marketing trials. George Clinical combines scientific and clinical leadership with expert trial delivery capability to create a distinctive world-class service. George Clinical’s parent organization, The George Institute for Global Health, is a leader in chronic disease research, with a global network of experts with whom George Clinical engages. George Clinical delivers an operationally supported, internationally recognized scientific leadership service, bringing together an extensive series of investigator networks that allow George Clinical to provide customizable clinical trial excellence from trial design through all aspects of delivery.

Contact: [email protected]

Website: www.georgeclinical.com

LinkedIn: https://www.linkedin.com/company/george-clinical-pty-ltd

Twitter: https://twitter.com/george_clinical

Facebook: https://www.facebook.com/georgeclinical  

About The George Institute for Global Health and George Institute China

The George Institute for Global Health is a non-profit medical and healthcare research organization with a mission to improve the health of millions of people worldwide by providing the best evidence to guide critical health decisions, engaging with decision-makers to enact real change, targeting global epidemics – particularly of chronic diseases and injury – and focusing on vulnerable populations in both rich and poor countries. Established in 1999 in Australia and affiliated with The University of Sydney, the Institute today has four centers in Australia, China, India and the United Kingdom. It is affiliated with Peking University Health Science Center in China, the University of Hyderabad in India and the University of Oxford in the United Kingdom.

Globally, The George Institute has projects in more than 50 countries, has raised more than $500 million for global health research, and has been ranked among the top 10 research institutions in the world for scientific impact by the SCImago Institution Rankings World Report in 2011, 2012, 2013 and 2014. For more information, please visit:

Website: www.georgeinstitute.org or www.georgeinstitute.org.cn

WeChat: The_George_Institute

LinkedIn: www.linkedin.com/company/the-george-institute-for-global-health

Twitter: twitter.com/georgeinstitute

Facebook: www.facebook.com/thegeorgeinstitute

About Cardio Union

Cardio Union was co-founded by multiple Chinese well-known cardiologists in June 2015. It has developed into an all-round emerging healthcare industry including tele-medicine, entity medicine, teaching and research, diseases management and academic communication. And become a leading healthcare organization which focuses on the prevention and treatment of cardiology diseases. With the rapid development of Cardio Union, its expert team is also expanding. At present, 388 national cardiovascular disease experts have officially signed up as core experts of Cardio Union, 316 of them are chief physicians and professors; 72 of them are deputy chief physicians and associate professors. The network covers 30 provinces and 68 major cities, and engaged in 28 medical centers.

We hope that, based on our expert resources and the complete line of Internet products, through Cardio Union and its subsidiaries, provide a high level of medical care, teaching and research, academic and technology support to hospitals, doctors, patients, Medical & Device manufacturers and strategic partners, Cardio Union will become a large-scale, influential and branded cardiovascular specialist medical service institution.

Website: http://www.cardiounion.cn/ 

Source: George Clinical